FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors

Fetal hemoglobin (HbF) improves the clinical severity of sickle cell disease (SCD), therefore, research to identify HbF-inducing agents for treatment purposes is desirable. The focus of our study is to investigate the ability of FK228 analogues to induce HbF using a novel KU812 dual-luciferase repor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Makala, Levi, Di Maro, Salvatore, Lou, Tzu-Fang, Sivanand, Sharanya, Ahn, Jung-Mo, Pace, Betty S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359661/
https://ncbi.nlm.nih.gov/pubmed/22655179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/428137
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak